ENTPD1 and non-small cell lung carcinoma: TGF-β pathway increases the expression of CD39 and CD73 in MDSCs by activating hypoxia-inducible factor-1 (HIF-1) and hence suppressing T cells’ and NK cells’ activity in non-small-cell lung cancer (NSCLC) [86].